Skip to Content

Healthy Living for All

Colleagues across our Schools and Faculties are dedicated to deepening our understanding of diseases, and developing solutions and treatments for them.

Our expertise in conducting clinical trials and our world leading facilities in cancer and precision medicine research are a testament to the breakthroughs that Queen’s research has facilitated over the decades. We are also leading the way in developing strategies and initiatives which mitigate against the worst effects of illness and which act as preventative agents to illnesses developing in the first place.

A strong public health approach, focusing on community well-being and cultural enrichment, aligned with a commitment to educational opportunity and social justice drives our pledge to improve health outcomes which can reduce inequalities across society.

Impact Case Studies

A New Approach to Weaning Critically Ill Patients from Mechanical Ventilation across the UK

Healthy Living for All

Researchers at Queen’s have identified ways to optimise inter-disciplinary collaboration in weaning infants and children from mechanical ventilation.

To date over two-thirds of UK paediatric intensive care units have adopted the protocolised weaning intervention that was designed based on this research.

A Vision For Healthy Urban Design: Non-Communicable Disease (NCD) prevention

Healthy Living for All

In partnership with University of Melbourne, researchers from Queen's are combining advanced AI and computer modelling to come up with ways future cities can be designed to prevent non-communicable diseases (NCDs).

Adverse Childhood Experiences in South Africa

Healthy Living for All

Building on a unique survey carried out at Queen’s University Belfast, this project explores policy development in mental health issues and support for young people from adverse backgrounds in South Africa and Northern Ireland.

Development of a Biopsychosocial Translational Research Programme

Healthy Living for All

Those exposed to armed conflict have a higher prevalence of mental health and psychosocial difficulties. Researchers from Queen's and Columbia, are exploring the evidence base for the effectiveness of these interventions to come up with new initiatives.

Diabetic Retinopathy: From Screening To Treatment: A sustainable model for diabetic retinopathy in the Philippines

Healthy Living for All

Researchers from Queen's in collaboration with international partners are pushing advances in diabetic retinopathy creating a sustainable model to reduce blindness and visual impairment.

Improving Healthcare for Children with Cerebral Palsy via Surveillance

Healthy Living for All

Researchers at Queen’s have improved the wellbeing of children living with cerebral palsy by conducting surveillance of patients with the condition and guiding the associated research undertaken by the Northern Ireland Cerebral Palsy Register (NICPR).

Improving Healthcare management and government policy through data analytics driven modelling

Healthy Living for All

Effective healthcare provision relies on understanding how factors such as illness and age underpin a patient’s progress through the healthcare system.

A new suite of statistical models developed in Queen’s University Belfast addresses this major challenge through novel front-end integration of data analytics. These models provided government officials and healthcare managers with the tools they needed to set policy and allocate resources in both normal and emergency circumstances:

Covid19 Alert level setting (Government policy): Data analytics informed local and national coronavirus alert level setting.

Staff deployment (Healthcare Management): Model-driven changes for shift times in the Ulster Hospital Belfast Emergency Department, resulting in a 14% reduction in waiting times to under 60 minutes for an additional 10,000 patients in one year.

Improving treatment and quality of life for patients with Prostate Cancer

Healthy Living for All

Prostate cancer affects 1 in 9 men in the UK, approximately 25% of whom will die from metastatic prostate cancer. Research from Queen’s University Belfast has meant that patients can benefit from participation in clinical trials. Those not involved in trials have benefitted from access to treatments that were not available as part of standard care. The research has also influenced clinical guidelines (locally and globally) and resulted in commercial impact through the development of Ra-223 treatment (Xofigo®).

Needle Free Delivery and mRNA Vaccines

Healthy Living for All

Researchers in the School of Pharmacy at Queen’s are developing the next generation of drug and vaccine delivery technologies.

Ophthalmology clinical trial hailed as one of the most important of the Decade

Healthy Living for All

Ophthalmology research at Queen's University Belfast has a long-standing international reputation which has been built around high-quality basic science, patient studies and clinical trials. Queen’s researchers have developed internationally-recognised expertise in the genetics and treatment of age-related macular degeneration (AMD).

Their clinical trial known as IVAN (Inhibition of VEGF in Age-related choroidal Neovascularisation) has led to a rapid impact on policy, practice, and debate around the globe.

PROSPER transforms global debate on the value of glasses for workers, improving productivity and well-being

Healthy Living for All

Most people have presbyopia, age-related decline in near vision, by age 50, but no trials had assessed workplace effects of correcting it until PROSPER (PROductivity Study of Presbyopia Elimination in Rural-dwellers) showed that Indian tea pickers randomly assigned to receive glasses correcting near vision picked 22% more tea per day than controls, with a glasses delivery cost of only US$10/participant.

This productivity impact is greater than that reported in any previous health intervention trial. The findings have led to programs providing glasses in Assam India and wider adoption of the Clear Vision Workspace model (as tested in PROSPER) by tea, coffee, automotive and textile sectors in India and Africa, leading to glasses delivery for 750,000 workers and consequent improvements in their productivity and well-being.

Reassembled, Slightly Askew - A Unique Immersive Theatrical Experience

Healthy Living for All, Inclusive and Cohesive Communities, Secure Connected Intelligence – AI and the Data Revolution

Reassembled, Slightly Askew (RSA) is an immersive audio-based artwork that transports you inside the head of artist Shannon Yee as she descends into coma from a rare brain infection and her re-emergence into the world with an acquired brain injury.

The work was created by a multidisciplinary team including Queen’s University’s Professor Paul Stapleton as composer/ Sound designer.

Shaping the World Health Organization’s (WHO) global agenda for sexual and reproductive health

Healthy Living for All

Research at Queen’s has improved the quality of sexual healthcare provision for the general population in NI and for all prisoners in the region.

The first long-acting, female-controlled preventative product against HIV

Healthy Living for All

Queen’s University is at the forefront of global efforts to develop products to protect women against sexually transmitted infection with human immunodeficiency virus (HIV).

For nearly two decades, researchers in the Queen’s School of Pharmacy have been supporting the development of a new drug-releasing vaginal ring to protect women from infection with the human immunodeficiency virus (HIV).

The monthly Dapivirine Ring, which is expected to reach market during 2022, will be the first long-acting option that women can use to reduce their risk of HIV transmission through vaginal sex, representing an important milestone in prevention technologies.

The Food Fortress- From a crisis to the formation of an innovative food quality assurance scheme

Healthy Living for All, Human-Environment Relations

The Food Fortress scheme developed by researchers at Queen's is recognised internationally as a world-leading risk management and feed quality assurance scheme.

Transformative Sexual and Reproductive Health Intervention

Healthy Living for All

Addressing the urgent need for gender transformative sexual and reproductive health (SRH) education, researchers at Queen's, in collaboration with Stellenbosch University South Africa, are developing and testing the feasibility of co-produced, culturally adapted SRH education interventions.

Transforming supportive cancer care for patients and families

Healthy Living for All

Researchers from Queen’s have transformed supportive care for cancer survivors and their families through the development of a new model for follow up care termed ‘The Recovery Package’.

Transforming the lives of people with Cystic Fibrosis

Healthy Living for All

Researchers from Queen’s have transformed the lives of people with Cystic Fibrosis by leading on the clinical development of treatments that address the underlying genetic disorder.

Uncovering the causes of a Major Crisis in the World Food Programme

Healthy Living for All, Human-Environment Relations, Inclusive and Cohesive Communities

For over 20 years, researchers at Queen’s have investigated the chemical contamination of foodstuffs for the benefit and safety of consumers around the world. In 2019 the team were called upon to identify the cause of a major contamination crisis in the UN World Food Programme (WFP).

Research Topics
  • Tackling cancer, infection, respiratory and eye diseases
  • Improving life course health and community well-being
  • Precision medicine and digital innovation to enhance healthcare solutions
  • Interventions and services to improve health and reduce inequality

Driving Innovation in Clinical Health Care Through the Belfast Region City Deal

Queen’s is leading the Institute for Research Excellence in Advanced Clinical Healthcare (iREACH), an integrated clinical research centre of excellence, and an NHS, industry, and research facility. It will transform the region’s ability to test new drugs, medical-technology, care pathways and societal interventions. It will leverage the opportunities that exist at the interface of medical research and digital transformation, resulting in better care for patients in a post-Covid world.